Spontaneous contractions of myometrium from humans, non-human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro

Authors: Wilson, R.J.1; Allen, M.J.1; Nandi, M.1; Giles, H.1; Thornton, S.2

Source: BJOG: An International Journal of Obstetrics & Gynaecology, Volume 108, Number 9, September 2001 , pp. 960-966(7)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objectives

To determine whether: 1. oxytocin receptor antagonists influence spontaneous contractions of myometrium from humans, non-human primates and rodents (in vitro), and 2. vasopressin V1a receptor antagonism is important for inhibition of spontaneous contractions in human myometrium. Design

In vitro pharmacology of spontaneous contractions of myometrium from humans and animals. Setting

The research laboratories of a university department of obstetrics and gynaecology and a pharmaceutical industry research centre. Interventions

Samples of human myometrium were obtained at caesarean section. Tissue strips were suspended in organ baths for isometric force recording. Cumulative concentration effect curves to a selective oxytocin receptor antagonist (L-371,257) and a mixed oxytocin/vasopressin V1a receptor antagonist (atosiban) were obtained. The effect of L-371,257 was also determined in myometrium from non-pregnant rats and marmosets. Main

outcome measures The inhibition of spontaneous myometrial contractions in vitro. Results

L-371,257 and atosiban significantly inhibited spontaneous activity of human myometrium in a concentration-related manner ( P<0.05 ), although the effect was more pronounced with L-371,257. Spontaneous contractions of myometrium from non-pregnant rats and marmosets were also inhibited by L-371,257 (atosiban was not tested). Conclusions

Spontaneous contractions of myometrium from humans, marmosets and rats are, at least in part, dependent on oxytocin receptor activity, in vitro. L-371,257 and atosiban may be inverse agonists. Selective non-peptide oxytocin receptor antagonists may be effective tocolytics.

Document Type: Research article

DOI: 10.1111/j.1471-0528.2001.00226.x

Affiliations: 1: Receptor Pharmacology Unit, GlaxoSmithKline Medicines Research Centre, Stevenage, UK 2: Department of Biological Sciences, University of Warwick, Coventry, UK

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A